GlassScriptPhysician profile
David Abovian
NPI 1326349960
$2,259.99
in general payments reported to CMS, 2019-2025
22 companies · $1,389 in 2025
The $1,389 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.73 · 2022: $217 · 2023: $581 · 2024: $56.05 · 2025: $1,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,831 · Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,830.85 |
| Education | $194.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $526.74 | 2022-2025 | |
| Abbvie INC. | $295.22 | 2023-2025 | Rinvoq |
| Sun Pharmaceutical Industries INC. | $193.93 | 2023-2025 | Winlevi, Blu-U |
| Amgen INC. | $181.42 | 2021-2025 | Otezla, Otezla |
| Incyte Corporation | $174.89 | 2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $156.92 | 2022-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $146.03 | 2025 | Tremfya |
| Leo Pharma INC. | $118.63 | 2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $70.46 | 2025 | Taltz, Ebglyss |
| Novartis Pharmaceuticals Corporation | $54.04 | 2025 | |
| Pfizer INC. | $53.19 | 2025 | |
| Bioventus LLC | $49.16 | 2025 | Exogen Ultrasound Bone Healing System |
| Hologic Sales and Service, LLC | $38.93 | 2024 | Thinprep 2000 Processor, Aptima |
| Allergan, INC. | $30.88 | 2022 | |
| Verrica Pharmaceuticals INC. | $24.36 | 2025 | Ycanth |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $23.18 | 2025 | Novosorb Btm |
| E.R. Squibb & Sons, L.L.C. | $22.27 | 2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $22.19 | 2025 | Zoryve |
| Smith+Nephew, INC. | $21.11 | 2025 | Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $19.58 | 2025 | Nuzyra |
| Tolmar, INC. | $19.13 | 2025 | Jatenzo |
| Galderma Laboratories, L.P. | $17.73 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Abovian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.